Alto Neuroscience (ANRO) PT Lowered to $36 at Baird
Tweet
Share
E-mailGet Alerts ANRO Hot Sheet
Price: $22.93 +0.84%
Rating Summary:
11 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Rating Summary:
11 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
Baird analyst Brian Skorney lowered the price target on Alto Neuroscience (NYSE: ANRO) to $36.00 (from $38.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Incyte (INCY) PT Raised to $105 at Truist Securities
- Regenxbio Inc. (RGNX) PT Raised to $32 at Baird
- Primaris REIT (PMZ-U:CN) PT Raised to Cdn$25 at CIBC
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
